InvestorsHub Logo
Followers 827
Posts 119559
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 781

Thursday, 07/20/2023 12:33:06 PM

Thursday, July 20, 2023 12:33:06 PM

Post# of 803
ABT 2Q23 Results by Business Segment


%Corp YoY Growth
Segment Sales (const currency)

Medical devices* 43% +14%
Diagnostics 23% -46%†
Nutrition 21% +10%
Branded generics 13% +13%

62% of overall corporate sales were ex-US.

*Includes diabetes care.

†2Q23 COVID-diagnostics sales were $263M (11% of total 2Q23 diagnostic sales) vs $2.3B in 2Q22; excluding COVID diagnostics, 2Q23 diagnostics sales were +7% YoY.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News